India’s first indigenously developed Pneumonia vaccine

Question: Which of the following firm has developed the first indigenously developed Pneumonia vaccine which received DGCI nod recently?
(a)Zydus Wellness
(b)Biocon
(c)Serum Institute of India
(d) Abott Pharmaceuticals
Answer: (c)
Related facts:

  • The Drug Controller General of India (DCGI) has given its approval to the first fully indigenously developed conjugate vaccine for pneumonia developed by Serum Institute of India Pvt. Ltd.
  • The vaccine is named as Pneumococcal Polysaccharide Conjugate Vaccine. Serum Institute first obtained the approval of DCGI to conduct Phase I, Phase II and Phase III clinical trials of Pneumococcal Polysaccharide Conjugate Vaccine in India. 
  • These trials have since been concluded within the country.
  • The said Company has also conducted these clinical trials in another country i.e. Gambia.
  • Pneumonia vaccine in India:This is the first indigenously developed vaccine in the field of pneumonia. 
  • Such vaccine are imported by licensed importers in the country since the manufacturers were all vaccine companies based outside India.
  • This vaccine is used for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” in infants.

Author: Himanshu Shukla

Links:

https://www.pib.gov.in/PressReleasePage.aspx?PRID=1638731 https://www.thehindu.com/sci-tech/health/first-indigenous-vaccine-for-infant-pneumonia-approved/article32095084.ece